Related Experiment Video
Updated: May 4, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Renal involvement in antiphospholipid syndrome.
Guillermo J Pons-Estel1, Ricard Cervera
1Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain, gponsestel@yahoo.com.
Antiphospholipid syndrome (APS) can cause serious kidney problems, including hypertension, renal failure, and specific lesions like renal artery stenosis and APS nephropathy. Early diagnosis and treatment are crucial for managing these renal complications.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Renal involvement is a significant, yet underrecognized, complication in patients with antiphospholipid syndrome (APS).
- Kidney issues can manifest in both primary APS and systemic lupus erythematosus-associated APS.
- Understanding these renal manifestations is critical for patient management.
Purpose of the Study:
- To review the spectrum of renal abnormalities associated with antiphospholipid syndrome (APS).
- To discuss the diagnostic approaches for renal complications in APS.
- To outline current treatment strategies for renal involvement in APS.
Main Methods:
- Review of clinical and laboratory features of renal involvement in APS.
- Analysis of pathological renal lesions, including glomerular and vascular abnormalities.
- Examination of diagnostic criteria and therapeutic options for APS-related kidney disease.
Main Results:
- Clinical features include hypertension, hematuria, acute renal failure, and progressive chronic renal insufficiency.
- Pathological findings encompass renal artery stenosis, venous thrombosis, glomerular lesions (APS nephropathy), and thrombotic microangiopathy.
- APS can lead to end-stage renal disease and allograft vascular thrombosis.
Conclusions:
- Renal involvement in APS presents with diverse clinical and pathological manifestations.
- Prompt diagnosis and comprehensive management are essential to mitigate kidney damage and improve outcomes in APS patients.
- Further research is needed to fully elucidate the mechanisms and optimize treatments for APS nephropathy.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Nephrotic Syndrome I : Introduction
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

